Advertisement
New Zealand markets closed
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NZD/USD

    0.5985
    +0.0010 (+0.16%)
     
  • NZD/EUR

    0.5543
    +0.0010 (+0.18%)
     
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD

    2,254.80
    +16.40 (+0.73%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • NZD/JPY

    90.4600
    +0.0670 (+0.07%)
     

Pharmaceutical Drugs Industry: Global Competitive Landscape 2021

ReportLinker
ReportLinker

Report Scope: This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies and company profiles are discussed in detail.

New York, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical Drugs Industry: Global Competitive Landscape 2021" - https://www.reportlinker.com/p06327315/?utm_source=GNW


The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe and Japan.

Report Includes:
- 71 data tables and 54 additional tables
- A brief general overview of the global pharmaceutical drugs industry competitive landscape
- Analyses of the global market trends, with historic market revenue for 2016 to 2021, estimates for 2022, market forecasts for 2022-2026, and projections of compound annual growth rates (CAGRs) through 2027
- Assessment of major driving factors, opportunities and challenges in this innovation driven market, with emphasis on recent developments in the pharmaceutical industry
- Highlights of the current and future market potential of pharmaceutical industry along with a detailed analysis of the competitive environment, regulatory scenario and clinical trails
- Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on recent developments and region-specific macroeconomic factors on global pharmaceutical drugs marketplace
- Market assessment of the COVID-19 impact on the global pharmaceutical drugs market, along with its implications on demand and supply, price impact and various government strategic decisions
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the leading pharma manufacturers, including Abbott, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Pfizer Inc., Sanofi Corp., Takeda Pharmaceutical Co. Ltd. and Zydus Cadila

Summary:
This report discusses the pharmaceutical industry and its competitive landscape in terms of major player market ranking and top pharmaceutical drugs. Company profiles of the top fifty pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends are well researched and analyzed in this report.

Study Goals and Objectives:
The goals and objectives of this study include -
- Defining and discussing the competitive landscape of the global pharmaceutical drugs market in 2021.
- Competitive ranking of the top fifty pharmaceutical companies in the market
- Profiling major players and analyzing market share, core competencies and strategies in the pharmaceutical drugs market.
- Tracking alliances, joint ventures, mergers and acquisitions, new product development and R&D in the global pharmaceutical drugs market.

Reasons for Doing This Study
With long life expectancy and emerging economies increasing their expenditure on healthcare, there is an increased demand for technologically superior pharmaceutical drugs. More stringent regulations, specifically in the mature markets of the U.S. and Europe, compel pharmaceutical manufacturers to launch sophisticated drugs that incorporate new materials, focus on in-depth indications and generate additional new data.
Read the full report: https://www.reportlinker.com/p06327315/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001